Literature DB >> 26729871

PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer.

Jaekwang Jeong1, Joshua N VanHouten1, Pamela Dann1, Wonnam Kim1, Catherine Sullivan2, Herbert Yu3, Lance Liotta4, Virginia Espina4, David F Stern5, Peter A Friedman6, John J Wysolmerski7.   

Abstract

In the lactating mammary gland, the plasma membrane calcium ATPase2 (PMCA2) transports milk calcium. Its expression is activated in breast cancers, where high tumor levels predict increased mortality. We find that PMCA2 expression correlates with HER2 levels in breast cancers and that PMCA2 interacts with HER2 in specific actin-rich membrane domains. Knocking down PMCA2 increases intracellular calcium, disrupts interactions between HER2 and HSP-90, inhibits HER2 signaling, and results in internalization and degradation of HER2. Manipulating PMCA2 levels regulates the growth of breast cancer cells, and knocking out PMCA2 inhibits the formation of tumors in mouse mammary tumor virus (MMTV)-Neu mice. These data reveal previously unappreciated molecular interactions regulating HER2 localization, membrane retention, and signaling, as well as the ability of HER2 to generate breast tumors, suggesting that interactions between PMCA2 and HER2 may represent therapeutic targets for breast cancer.

Entities:  

Keywords:  ErbB2; HSP-90; calcium pumps; epidermal growth factor receptor; receptor internalization

Mesh:

Substances:

Year:  2016        PMID: 26729871      PMCID: PMC4725473          DOI: 10.1073/pnas.1516138113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer.

Authors:  Joshua VanHouten; Catherine Sullivan; Caroline Bazinet; Tom Ryoo; Robert Camp; David L Rimm; Gina Chung; John Wysolmerski
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

2.  Null mutation in the gene encoding plasma membrane Ca2+-ATPase isoform 2 impairs calcium transport into milk.

Authors:  Timothy A Reinhardt; John D Lippolis; Gary E Shull; Ronald L Horst
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

3.  Application of fusion protein 4D5 scFv-dibarnase:barstar-gold complex for studying P185HER2 receptor distribution in human cancer cells.

Authors:  Julia L Ivanova; Evelina F Edelweiss; Olga G Leonova; Taras G Balandin; Vladimir I Popenko; Sergey M Deyev
Journal:  Biochimie       Date:  2012-04-17       Impact factor: 4.079

Review 4.  The plasma membrane calcium pump: new ways to look at an old enzyme.

Authors:  Raffaele Lopreiato; Marta Giacomello; Ernesto Carafoli
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

5.  Association of p185neu with microfilaments via a large glycoprotein complex in mammary carcinoma microvilli. Evidence for a microfilament-associated signal transduction particle.

Authors:  C A Carraway; M E Carvajal; Y Li; K L Carraway
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

Review 6.  Plasma membrane calcium ATPases as novel candidates for therapeutic agent development.

Authors:  Emanuel E Strehler
Journal:  J Pharm Pharm Sci       Date:  2013       Impact factor: 2.327

7.  Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.

Authors:  L N Klapper; H Waterman; M Sela; Y Yarden
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

8.  ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.

Authors:  Corina Marx; Jason M Held; Bradford W Gibson; Christopher C Benz
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

9.  The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.

Authors:  Rosa A Cardone; Antonia Bellizzi; Giovanni Busco; Edward J Weinman; Maria E Dell'Aquila; Valeria Casavola; Amalia Azzariti; Anita Mangia; Angelo Paradiso; Stephan J Reshkin
Journal:  Mol Biol Cell       Date:  2007-03-01       Impact factor: 4.138

Review 10.  Remodeling of calcium signaling in tumor progression.

Authors:  Yih-Fung Chen; Ying-Ting Chen; Wen-Tai Chiu; Meng-Ru Shen
Journal:  J Biomed Sci       Date:  2013-04-17       Impact factor: 8.410

View more
  25 in total

Review 1.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

2.  ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.

Authors:  Claudia Capparelli; Timothy J Purwin; Shea A Heilman; Inna Chervoneva; Peter A McCue; Adam C Berger; Michael A Davies; Jeffrey E Gershenwald; Clemens Krepler; Andrew E Aplin
Journal:  Cancer Res       Date:  2018-08-16       Impact factor: 12.701

3.  Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.

Authors:  Jaekwang Jeong; Jungmin Choi; Wonnam Kim; Pamela Dann; Farzin Takyar; Julia V Gefter; Peter A Friedman; John J Wysolmerski
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

4.  Calcium Metabolism and Breast Cancer: Echoes of Lactation?

Authors:  Diego Grinman; Diana Athonvarungkul; John Wysolmerski; Jaekwang Jeong
Journal:  Curr Opin Endocr Metab Res       Date:  2020-11-21

5.  NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland.

Authors:  Jaekwang Jeong; Wonnam Kim; Julie Hens; Pamela Dann; Pepper Schedin; Peter A Friedman; John J Wysolmerski
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

Review 6.  The calcium-cancer signalling nexus.

Authors:  Gregory R Monteith; Natalia Prevarskaya; Sarah J Roberts-Thomson
Journal:  Nat Rev Cancer       Date:  2017-04-07       Impact factor: 60.716

7.  The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.

Authors:  Jaekwang Jeong; Joshua N VanHouten; Wonnam Kim; Pamela Dann; Catherine Sullivan; Jungmin Choi; W Bruce Sneddon; Peter A Friedman; John J Wysolmerski
Journal:  J Biol Chem       Date:  2017-02-24       Impact factor: 5.157

8.  Control of cell state transitions.

Authors:  Melinda Halasz; Nora Rauch; Oleksii S Rukhlenko; Vadim Zhernovkov; Thomas Prince; Kieran Wynne; Stephanie Maher; Eugene Kashdan; Kenneth MacLeod; Neil O Carragher; Walter Kolch; Boris N Kholodenko
Journal:  Nature       Date:  2022-09-14       Impact factor: 69.504

9.  Asporin Interacts With HER2 to Promote Thyroid Cancer Metastasis via the MAPK/EMT Signaling Pathway.

Authors:  Shaohua Zhan; Tianxiao Wang; Jingying Li; Hanyang Zhu; Wei Ge; Jinming Li
Journal:  Front Oncol       Date:  2022-05-02       Impact factor: 5.738

10.  Subtype specific targeting of calcium signaling in breast cancer.

Authors:  Monish Ram Makena; Rajini Rao
Journal:  Cell Calcium       Date:  2019-11-12       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.